Pay in 4 interest-free payments of $6.60 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Saxenda (liraglutide 3 mg) is a GLP-1 receptor agonist licensed in the UK for weight management in adults with obesity or overweight with comorbidities There is no established pharmacological mechanism by which Saxenda would directly interfere with sleep-wake cycles Common gastrointestinal side effects such as nausea, abdominal discomfort, or reflux may indirectly disrupt sleep quality in some patients Fatigue is a recognised common side effect of Saxenda that may affect daytime alertness and perceived sleep patterns Patients experiencing persistent sleep problems whilst taking Saxenda should consult their GP or prescribing clinician for personalised assessment and management Table of Contents Understanding Saxenda and Its Mechanism of Action Saxenda (liraglutide 3 mg) is a prescription medicine licensed in the UK for weight management in adults with a BMI 30 kg/m (obesity) or 27 kg/m with at least one weight-related comorbidity
Here, we provide an overview of some of the latest findings about the function, the prognostic impact and potential treatment strategies of iron in patients with MDS and AML
What should I do if I experience side effects after a B12 injection at home
This approach gives you the superior long-term efficacy of tirzepatide, as demonstrated in the SURMOUNT trial results , without the ongoing risks of combination therapy
